C. diff. Spores and More

Professor Simon Cutting joins us and shares his thoughts and scientific research focused on

C.difficile prevention, treatments, and probiotics.

The C.diff. infection concept of 20 years ago is not what it is today. Professor Cutting reviews the landscape of C.difficile from the farms, animals, to humans and the differences from country to country.

Join us with our guest: Ms. Courtney Jones, Upstream Marketing Manager and Senior Project Manager at Rebiotix, a Ferring Pharmaceuticals company, focused on harnessing the power of the human microbiome to treat debilitating diseases.

Ms. Jones will be discussing and explaining the Microbiome. What Microbes are and the difference between the good, bad, and in between and what the Microbiome has to do with C.diff. treatment.

There is a lot to learn about the science of the Microbiome and Ms. Jones will certainly be educating us on this episode, Researching Bugs as Drugs to Fight C.diff..

Join us with our guest: Ms. Courtney Jones, Upstream Marketing Manager and Senior Project Manager at Rebiotix, a Ferring Pharmaceuticals company, focused on harnessing the power of the human microbiome to treat debilitating diseases.

Ms. Jones will be discussing and explaining the Microbiome. What Microbes are and the difference between the good, bad, and in between and what the Microbiome has to do with C.diff. treatment.

There is a lot to learn about the science of the Microbiome and Ms. Jones will certainly be educating us on this episode, Researching Bugs as Drugs to Fight C.diff..

The Centers for Medicare and Medicaid Services (CMS) regulations, revised in the past few years, will improve infection control in long term care facilities and must be fully implemented by November 2019. Improved infection control practices in Long Term Care Facilities (LTCF’s) should result in a reduction in healthcare-associated infections, including C. difficile infections.

In 2019, LTCFs participating in Medicare must be in full compliance with part 483.80 of title 42 of the Code of Federal Regulations (CFR). The IPCP at a single LTCF was evaluated for compliance with these revised

regulations.

Join our guests Doe Kley, RN, CIC, MPH

and R. Deane Kirchner, RN as they discuss and review The infection control revisions in the CMS requirements for LTCF’s. * The unique challenges that LTCF’s face with infection control and antimicrobial

stewardship.* Evidence-based recommendations for the prevention of C. diff in LTCF’s. and much more.

The Centers for Medicare and Medicaid Services (CMS) regulations, revised in the past few years, will improve infection control in long term care facilities and must be fully implemented by November 2019. Improved infection control practices in Long Term Care Facilities (LTCF’s) should result in a reduction in healthcare-associated infections, including C. difficile infections.

In 2019, LTCFs participating in Medicare must be in full compliance with part 483.80 of title 42 of the Code of Federal Regulations (CFR). The IPCP at a single LTCF was evaluated for compliance with these revised

regulations.

Join our guests Doe Kley, RN, CIC, MPH

and R. Deane Kirchner, RN as they discuss and review The infection control revisions in the CMS requirements for LTCF’s. * The unique challenges that LTCF’s face with infection control and antimicrobial

stewardship.* Evidence-based recommendations for the prevention of C. diff in LTCF’s. and much more.

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Join us with guest Dr. David Lyerly, PhD - Co-Founder, CSO of TechLab. Dr. Lyerly will be discussing C.diff. (C.difficile) in the IBD Patient ~ the research,clinical assays for enteric and autoimmune diseases.

Dr. Lyerly will also be discussing the symptoms and lab testing focused on a C. difficile infection in the IBD patient.

If you have specific questions to be shared with our guests during the show - please e-mail them ahead of time to [email protected] Thank you.

Join us with our guests Elizabeth A.Myers,BSN, RN and Wendy Benson, MBA, OTR/L as we discuss

the challenges of today's healthcare and their newly published book, "The Confident Patient" which answers the many questions and guides patients and families through the healthcare mazes. Have your tablets, pen and paper ready to jot down notes as we discuss healthcare solutions and helpful information for the entire family.